What is it about?

Microorganisms, including fungi, have the ability to develop resistance to the drugs commonly used to treat the infections they cause. The monitoring of drug resistance patterns is present is most regions around the globe, but there is a lack of data from sub-Saharan Africa. In this review we looked at published studies on Candida drug resistance in the subcontinent.

Featured Image

Why is it important?

We found that the drug resistance patterns are not uniform in the different regions where studies have been conducted. Due to the emergence of Candida drug resistance to widely used antifungal drugs, we proposed a revision of current prescribing guidelines and the establishment of surveillance programmes in sub-Saharan Africa.

Read the Original

This page is a summary of: Candida antifungal drug resistance in sub-Saharan African populations: A systematic review, F1000Research, January 2017, Faculty of 1000, Ltd., DOI: 10.12688/f1000research.10327.2.
You can read the full text:

Open access logo


The following have contributed to this page